Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
LianBio
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
4
| Jahn Brianne (Chief Business Officer) has filed a Form 4 on LianBio|
Txns:
| Granted 224,005 shares
@ $0 |
|
| 03/31/2023 |
4
| QIAN JIANG (SVP, China General Manager) has filed a Form 4 on LianBio|
Txns:
| Granted 224,005 shares
@ $0 |
|
| 03/31/2023 |
4
| Wang Yizhe (CEO) has filed a Form 4 on LianBio|
Txns:
| Granted 907,498 shares
@ $0 |
|
| 03/31/2023 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 325,901 shares
@ $0 |
|
| 01/24/2023 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 464,099 options to buy
@ $2.66, valued at
$1.2M
|
|
| 01/24/2023 |
4
| Jahn Brianne (Chief Business Officer) has filed a Form 4 on LianBio|
Txns:
| Granted 318,995 options to buy
@ $2.66, valued at
$848.5k
|
|
| 01/24/2023 |
4
| QIAN JIANG (SVP, China General Manager) has filed a Form 4 on LianBio|
Txns:
| Granted 318,995 options to buy
@ $2.66, valued at
$848.5k
|
|
| 01/24/2023 |
4
| Wang Yizhe (CEO) has filed a Form 4 on LianBio|
Txns:
| Granted 1,292,324 options to buy
@ $2.66, valued at
$3.4M
|
|
| 01/05/2023 |
4
| QIAN JIANG (SVP, China General Manager) has filed a Form 4 on LianBio|
Txns:
| Sold 2,239 shares
@ $1.6532, valued at
$3.7k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Silbermann Susan Michele (Director) has filed a Form 4 on LianBio|
Txns:
| Granted 36,300 options to buy
@ $2.52, valued at
$91.5k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Yu Debra (See Remarks) has filed a Form 4 on LianBio|
Txns:
| Exercised 1,000,000 options to buy
@ $1.71, valued at
$1.7M
|
|
| 04/08/2022 |
4
| Chen Wei Wei (Director) has filed a Form 4 on LianBio|
Txns:
| Granted 72,600 options to buy
@ $4.95, valued at
$359.4k
|
|
| 01/03/2022 |
4
| GIANAKAKOS ANASTASIOS (Director) has filed a Form 4 on LianBio|
Txns:
| Exercised 36,548 options to buy
@ $6.49, valued at
$237.2k
|
|
| 01/03/2022 |
4
| QIAN JIANG (China General Manager) has filed a Form 4 on LianBio|
Txns:
| Granted 69,588 shares
@ $0 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on LianBio|
Txns:
| Bought 2,250,000 shares
@ $16, valued at
$36M
Bought 20,000 shares
@ $13.51, valued at
$270.2k
|
|
| 11/03/2021 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on LianBio|
Txns:
| Bought 120,000 shares
@ $15.5, valued at
$1.9M
Bought 100,000 shares
@ $13.5, valued at
$1.4M
Converted 3,715,510 shares
@ $0
Converted 14,619,500 shares
@ $0
Converted 14,619,500 shares
@ $0
Converted 2,923,000 shares
@ $0
Converted 2,477,005 shares
@ $0
Converted 635,369 options to buy
@ $0
Converted 2,500,000 options to buy
@ $0
Converted 2,500,000 options to buy
@ $0
Converted 500,000 options to buy
@ $0 |
|
| 11/01/2021 |
4
| QIAN JIANG (China General Manager) has filed a Form 4 on LianBio|
Txns:
| Granted 409,343 options to buy
@ $16, valued at
$6.5M
|
|
| 11/01/2021 |
4
| Silbermann Susan Michele (Director) has filed a Form 4 on LianBio|
Txns:
| Granted 72,600 options to buy
@ $16, valued at
$1.2M
|
|
| 11/01/2021 |
4
| Jahn Brianne (Chief Business Officer) has filed a Form 4 on LianBio|
Txns:
| Granted 330,942 options to buy
@ $16, valued at
$5.3M
|
|
| 11/01/2021 |
4
| Wu Jesse (Director) has filed a Form 4 on LianBio|
Txns:
| Granted 72,600 options to buy
@ $16, valued at
$1.2M
|
|
| 11/01/2021 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 229,538 options to buy
@ $16, valued at
$3.7M
|
|
| 11/01/2021 |
4
| Yu Debra (See Remarks) has filed a Form 4 on LianBio|
Txns:
| Granted 747,227 options to buy
@ $16, valued at
$12M
|
|
|
|